Warsaw Glia Symposium 2025
On behalf of the organizers, we invite you to an international scientific meeting dedicated to the dynamically developing field of glial cell research.
The Warsaw Glia Symposium 2025 will take place on October 16 and 17 in Warsaw. It is a recurring event, bringing together scientists at all stages of their careers interested in astrocytes, oligodendrocytes, microglia, and the crucial role these cells play in the brain.
The mission of the Warsaw Glia Community is to foster collaboration, share innovative discoveries, and strengthen the glial research community in Warsaw, Poland, and beyond. The symposium, organized under the patronage of the University of Warsaw, aims to connect scientists from Warsaw institutions (including the University of Warsaw, the Medical University of Warsaw, and the Polish Academy of Sciences) with leading scientists from other national and international centers.
The event is open to scientists at all stages of their careers - from undergraduate students to experienced researchers. Participation is free of charge.
The organizers and speakers include researchers from our Institute: Luiza Stanaszek, PhD and Justyna Janowska, PhD from the NeuroRepair Department, and Mariusz Popek, PhD from the Department of Neurotoxicology.
For more details please visit: Warsaw Glia Symposium
Gold medal for enzybiotics
The research success of Prof. Izabela Sabała and Elżbieta Jagielska - ENZYBIOTICS - was honored with a Gold Medal by international jury of the E-NNOVATE 2025 Online International Innovation Summit (held June 20 – July 12, 2025)
E-NNOVATE is a renowned platform for creators, startups, scientists, and companies seeking to stand out on the international innovation scene. Over 300 inventions from around 30 countries participated in the 2025 edition, demonstrating the event's scope and importance.
Doctoral School - recruitment
Join us at Doctoral School of Translational Medicine
Application deadline: end of July 2025
For details - click the image below:
NAWA STRIM for Magdalena Winiarska
We are pleased to announce that the Polish National Agency for Academic Exchange (NAWA) has awarded Mossakowski Medical Research Institute Polish Academy of Sciences (MMRI PAS) funding for the implementation of a project under the Strategic Partnerships 2024 program.
The project titled "Strategy for the Development of Scientific Research in the Field of Cancer Immunotherapy" (STRIM) is one of only 11 projects (out of 142 submitted) selected for funding in the 2024 edition.
Its goal is to enhance MMRI’s research potential and scientific excellence in the area of cellular immunotherapy by establishing an international, long-term strategic partnership between MMRI and foreign partners: the Josep Carreras Leukaemia Research Institute (IJC) and the University of Oviedo (UO).
At MMRI, the STRIM project will be implemented by the Department of Immunology, led by Dr. hab. Magdalena Winiarska. On the IJC side, the project will be coordinated by Prof. Pablo Menendez, and at UO by Prof. Xose Puente.
Planned activities include, among others, enhancing MMRI's visibility by fostering networking and mobility of MMRI researchers, as well as disseminating project outcomes and knowledge about CAR-T therapies among scientists, medical professionals, and the broader public.
In addition, the expected improvement in MMRI’s research capacity may bring tangible benefits in the area of basic and translational research, potentially leading to the development of innovative cancer immunotherapies.
OPUS LAP for Prof. Bużańska
Congratulations to Prof. Leonora Bużańska,
whose international research project received funding in the OPUS 28 competition in the LAP (lead agency procedure) track.
The research of Prof. Bużańska's team will be conducted in cooperation with the team of the University of Luxembourg and will concern the pathology of Parkinson's disease.
Prof. Bużańska: "I am extremely proud that the team I lead from the Department of Stem Cell Bioengineering received the OPUS 28+LAP Weave grant. I would like to thank the NCN and partners from Luxembourg – this is a unique opportunity to explore the mechanisms of microglial aging and its impact on Parkinson's disease using innovative brain organoids.
This interdisciplinary approach will allow us not only to better understand the pathophysiology of neurodegenerative diseases, but also to develop potential therapeutic strategies. I am looking forward to working with the team of Prof. Jens Christian Schwamborn from Luxembourg – I believe that together we can achieve real progress in the treatment of neurodegenerative diseases. Using state-of-the-art in vitro models that resemble the structure of the human brain, we try to "build bridges" between basic science and practical solutions for patients and their families."
Project Summary
